search
Back to results

Non-surgical Peridontal Treatment on Cardiovascular Risk Markers

Primary Purpose

Cardiovascular Risk Markers, Chronic Periodontitis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Non-surgical periodontal treatment
Sponsored by
Kırıkkale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiovascular Risk Markers focused on measuring asymmetric dimethylarginine, endothelial nitric oxide synthase, homocysteine, monocyte chemoattractant protein-1

Eligibility Criteria

30 Years - 54 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Clinical diagnosis of severe chronic periodontitis

Clinical diagnosis of periodontal health

Exclusion Criteria:

Systemic diseases such as diabetes, cardiovascular disease

Periodontal treatment within the previous year

Drugs such as systemic steroids, non-steroidal anti-inflammatory drugs, immunosuppressants, hormone drugs, contraceptives, anticoagulants, cholesterol regulating drugs, systemic antibiotics, antioxidants within the previous 3 months

Pregnant or lactating

Consumed alcohol

Smoker

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    Non-surgical peridontal treatment

    Arm Description

    Patients with chronic periodontitis received non-surgical periodontal treatment, including scaling and root planing and polishing within 14 days under local anesthesia with manual and ultrasonic devices and standardized oral hygiene instructions including methods of tooth-brushing and interdental cleaning were also given to each one. A professional supragingival plaque control was applied on a regular basis every month.

    Outcomes

    Primary Outcome Measures

    Asymmetric dimethylarginine (ADMA)
    Serum Concentration (pg/mL)
    Endothelial nitric oxide synthase (eNOS)
    Serum Concentration (pg/mL)
    Homocysteine (Hcy)
    Serum Concentration (nmol/mL)
    Monocyte chemoattractant protein-1 (MCP-1)
    Serum Concentration (ng/mL)

    Secondary Outcome Measures

    Clinical periodontal parameter
    Clinical attachment level (mm)

    Full Information

    First Posted
    March 7, 2018
    Last Updated
    September 1, 2020
    Sponsor
    Kırıkkale University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04540328
    Brief Title
    Non-surgical Peridontal Treatment on Cardiovascular Risk Markers
    Official Title
    Effect of Non-surgical Peridontal Treatment on Cardiovascular Risk Markers in Patients With Severe Chronic Periodontitis
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    August 2015 (Actual)
    Primary Completion Date
    February 2016 (Actual)
    Study Completion Date
    August 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Kırıkkale University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The study evaluates the influence of non-surgical mechanical periodontal treatment in patients with severe chronic periodontitis on inflammatory markers related to risk for cardiovascular diseases
    Detailed Description
    A total of 80 non-smokers with systemically healthy, including 40 patients with severe chronic periodontitis and 40 periodontally health subjects were included into the present study. The probing depth, clinical attachment level, plaque index, gingival index and blood samples were collected at baseline and at the 3rd months after treatment and the serum levels of asymmetric dimethylarginine (ADMA), endothelial nitric oxide synthase (eNOS), homocysteine (Hcy), monocyte chemoattractant protein-1 (MCP-1) were determined with enzyme-linked immunosorbent assay (ELISA).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiovascular Risk Markers, Chronic Periodontitis
    Keywords
    asymmetric dimethylarginine, endothelial nitric oxide synthase, homocysteine, monocyte chemoattractant protein-1

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    80 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Non-surgical peridontal treatment
    Arm Type
    Other
    Arm Description
    Patients with chronic periodontitis received non-surgical periodontal treatment, including scaling and root planing and polishing within 14 days under local anesthesia with manual and ultrasonic devices and standardized oral hygiene instructions including methods of tooth-brushing and interdental cleaning were also given to each one. A professional supragingival plaque control was applied on a regular basis every month.
    Intervention Type
    Other
    Intervention Name(s)
    Non-surgical periodontal treatment
    Primary Outcome Measure Information:
    Title
    Asymmetric dimethylarginine (ADMA)
    Description
    Serum Concentration (pg/mL)
    Time Frame
    At the 3rd months after non-surgical periodontal treatment
    Title
    Endothelial nitric oxide synthase (eNOS)
    Description
    Serum Concentration (pg/mL)
    Time Frame
    At the 3rd months after non-surgical periodontal treatment
    Title
    Homocysteine (Hcy)
    Description
    Serum Concentration (nmol/mL)
    Time Frame
    At the 3rd months after non-surgical periodontal treatment
    Title
    Monocyte chemoattractant protein-1 (MCP-1)
    Description
    Serum Concentration (ng/mL)
    Time Frame
    At the 3rd months after non-surgical periodontal treatment
    Secondary Outcome Measure Information:
    Title
    Clinical periodontal parameter
    Description
    Clinical attachment level (mm)
    Time Frame
    At the 3rd months after non-surgical periodontal treatment

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    30 Years
    Maximum Age & Unit of Time
    54 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Clinical diagnosis of severe chronic periodontitis Clinical diagnosis of periodontal health Exclusion Criteria: Systemic diseases such as diabetes, cardiovascular disease Periodontal treatment within the previous year Drugs such as systemic steroids, non-steroidal anti-inflammatory drugs, immunosuppressants, hormone drugs, contraceptives, anticoagulants, cholesterol regulating drugs, systemic antibiotics, antioxidants within the previous 3 months Pregnant or lactating Consumed alcohol Smoker

    12. IPD Sharing Statement

    Learn more about this trial

    Non-surgical Peridontal Treatment on Cardiovascular Risk Markers

    We'll reach out to this number within 24 hrs